Wireless patches for continuous vital sign monitoring, symptoms and medication at the end-of-life in the palliative care unit: A prospective observational study
- PMID: 40828438
- DOI: 10.1007/s10877-025-01343-6
Wireless patches for continuous vital sign monitoring, symptoms and medication at the end-of-life in the palliative care unit: A prospective observational study
Abstract
Vital sign monitoring in palliative care could support symptom management and prediction, though its utility at the end-of-life remains critically discussed. This study aims to test a wireless device for continuous vital sign monitoring at the end-of-life. This prospective observational study included adult terminal care patients in the palliative care unit at a tertiary-care hospital (05/2023-03/2024). Continuous monitoring of heart rate (HR in beats/minute, bpm), respiratory rate, and temperature was conducted using VitalPatches (MediBioSense). Patient demographics, medications, and symptoms were further recorded. Linear mixed-effects models were applied for analyses. 30 patients (median age 70, 53.3% female, 90% with cancer) were included. Median patch duration was 88 h (IQR 35-153). Symptom load increased until death (p = 0.004), with weakness and impaired vigilance being prominent. From patch start to end, opioid use rose from 80 to 100% (p = 0.010), and benzodiazepine use from 50 to 80% (p = 0.015). All vital signs increased in daily and hourly intervals. Compared to three days prior, the HR increased as death approached: 3.70 bpm (-2 days, p < 0.001), 7.64 bpm (-1 day, p < 0.001), and 12.26 bpm (day of death, p < 0.001). Pain correlated with HR (r = 0.32, p < 0.001), and a 5 bpm HR increase over the previous 24 h was associated with imminent death within the following 24 h. Continuous vital sign monitoring in palliative care using VitalPatches is feasible and depicts vital sign changes at the end-of-life. A positive correlation of HR with pain was detected. These observations provide a rationale for larger studies investigating their relevance for life time prediction as well as symptom detection and management.
Keywords: Death; Monitoring, physiologic; Observational study; Palliative care; Prospective studies; Terminal care; Vital signs; Wearable electronic devices.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: This study was performed in line with the principles of the Declaration of Helsinki. All participants or their legal representatives gave written informed consent before enrolment. The study protocol and supporting documentation was approved by the local ethics committee (protocol number: 2022 − 1981_1, March 18th 2023). Data management and sharing: The data related to this study is maintained and managed according to organizational guidelines and ethical regulations. In the interest of patient confidentiality and anonymity, this information will not be made publicly available. Requests for further information can be directed to the corresponding author.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Community and hospital-based healthcare professionals perceptions of digital advance care planning for palliative and end-of-life care: a latent class analysis.Health Soc Care Deliv Res. 2025 Jun 25:1-22. doi: 10.3310/XCGE3294. Online ahead of print. Health Soc Care Deliv Res. 2025. PMID: 40580081
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Medically assisted hydration for adults receiving palliative care.Cochrane Database Syst Rev. 2023 Dec 14;12(12):CD006273. doi: 10.1002/14651858.CD006273.pub4. Cochrane Database Syst Rev. 2023. PMID: 38095590 Free PMC article.
References
-
- Radbruch L, De Lima L, Knaul F, Wenk R, Ali Z, Bhatnaghar S, et al. Redefining palliative care-a new consensus-based definition. J Pain Symptom Manage. 2020;60:754–64. https://doi.org/10.1016/j.jpainsymman.2020.04.027 . - DOI - PubMed - PMC
-
- Power J, Gouldthorpe C, Davies A. Vital signs in palliative care: a scoping review. Cancers (Basel). 2023;15(18): 4641. https://doi.org/10.3390/cancers15184641 . - DOI - PubMed
-
- Thomas JR. Normal vital signs as death approaches: commentary on Bruera. J Pain Symptom Manage. 2014;48(4):499. https://doi.org/10.1016/j.jpainsymman.2014.05.017 . - DOI - PubMed
-
- Schellenberger S, Shi K, Steigleder T, Malessa A, Michler F, Hameyer L, et al. A dataset of clinically recorded radar vital signs with synchronised reference sensor signals. Sci Data. 2020;7(1):291. https://doi.org/10.1038/s41597-020-00629-5 . - DOI - PubMed - PMC
-
- Kant N, Peters GM, Voorthuis BJ, Groothuis-Oudshoorn CGM, Koning MV, Witteman BPL, et al. Continuous vital sign monitoring using a wearable patch sensor in obese patients: a validation study in a clinical setting. J Clin Monit Comput. 2022;36(5):1449–59. https://doi.org/10.1007/s10877-021-00785-y . - DOI - PubMed
LinkOut - more resources
Full Text Sources